These Five Biotech Stocks Will Roar Back in 2016
Since 2009, the Nasdaq Biotechnology Index has soared more than 250%, outperforming the major stock-market indices by 300%+. However, biotech has dipped along with the rest of the market, taking a 22% nosedive since the start of the year. Demand for new medications isn't going anywhere, though, so biotech is just now reaching its potential to deliver breakthrough drugs like clockwork. That means today is an incredible opportunity to buy cutting-edge biotech companies at steep discounts. So, in this brand-new free report, I'm recommending to you five revolutionary biotech companies that will make profit-generating comebacks throughout 2016.